Repro Med Systems receives Investment Bank Analyst Rating Update
Investing.com - KORU Medical Systems reported on Wednesday third quarter earnings that beat analysts' forecasts and revenue that topped expectations. KORU Medical Systems...
Repro Med Systems (KRMD) reported Q3 EPS of ($0.03), $0.02 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $7.76 million versus the consensus...
1. Exelixis (NASDAQ:EXEL) broke away with a major move on Monday, and followed up on Tuesday, popping 98 cents, or 4%, to 24.56, with a session and multi-week high of 25.13, on...
KORU Medical Systems (NASDAQ:KRMD), providers of in-home infusion systems, popped on Thursday, running up 1.96, or 27.84%, to session and multi-week highs at 9.25, before pulling...
1. Advanced Micro Devices (NASDAQ:AMD) has been ramping since October, when it broke out of a falling wedge, popped out at about 30 and just kept running. On Wednesday it jumped...
KORU Medical Systems, Inc. designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. It offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing. The company also provides education and training materials to clinicians, patients, and patient advocates. It sells its products through direct sales and medical device distributors, as well as online. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Chester, New York.
|Average||4.833 (+42.575% Upside)|
|No. of Analysts||3|